Gardner Denver Medical acquires TriContinent Scientific

Gardner Denver Medical acquires TriContinent Scientific

— Strategic fit due to complementing product portfolios

— Complete solutions from one single source

PR Newswire

MUNICH, Germany, May 1, 2015 /PRNewswire/ — Gardner Denver’s Medical Group (“Gardner Denver”), a leader in flow control solutions primarily for medical and laboratory sectors, today announced the closing of its acquisition of TriContinent Scientific, Inc. (“TriContinent Scientific”).

Headquartered in Grass Valley, California, U.S., TriContinent Scientific is a leading manufacturer of OEM precision syringe pumps and a supplier to the world’s leading medical and biotechnology diagnostic and analytics equipment manufacturers. In addition to offering customized products tailored to customer needs, TriContinent Scientific offers five product lines: precision pumps, valves and syringes, XYZ robotics, microplate washers and manifolds, as well as pipettes and dispensers.

“The technology and portfolio of TriContinent Scientific is a perfect strategic fit for Gardner Denver’s Medical Group. With the addition of both a fantastic team and product set to our business, we are now able to extend our customer offerings to include liquid handling systems,” said Patrick Bennett, CEO of Gardner Denver´s Medical Group.

Gardner Denver plans to integrate TriContinent Scientific’s business and products under the name TriContinent. Adding TriContinent Scientific’s core competencies in syringe pumps and liquid handling robots for the lab automation market will enable Gardner Denver to offer complete solutions from a single source to its OEM and laboratory customers, giving the company a significant competitive edge.

“With Gardner Denver, we have found a strong partner that shares our mission and our vision,” said Lee Carter, CEO of TriContinent Scientific. “By accessing the longstanding distribution network of our new owner, we will be able to supply our highly sophisticated pumps and robots to an even broader, global customer base,” Carter said.

Financial terms of the transaction were not disclosed.

About Gardner Denver’s Medical Group:
Gardner Denver Medical is a leader in flow control products for medical, life sciences, and selected other industries – focused on solutions for OEMs. Innovation, global capabilities and a solutions centric approach to our customer’s success is at our core. Together, our Thomas and Welch-Ilmvac brands are serving more than 5,000 customers globally. A global production network with seven modern manufacturing facilities throughout the U.S., Europe and Asia allows fast and flexible reaction to our customer needs.

About Gardner Denver, Inc.
Gardner Denver, Inc. is a leading worldwide manufacturer of highly engineered products, including compressors, liquid ring pumps and blowers for various industrial, medical, environmental, transportation and process applications, pumps used in the petroleum and industrial market segments and other fluid transfer equipment, such as loading arms and dry break couplers, serving chemical, petroleum and food industries. Gardner Denver, Inc. is privately owned by affiliates of leading investment firm Kohlberg Kravis Roberts & Co L.P.

PwC Corporate Finance provided strategic advisory services to Gardner Denver during this transaction.

FORWARD-LOOKING STATEMENTS

All of the statements in this press release, other than historical facts, are forward-looking statements. As a general matter, forward-looking statements are those focused upon anticipated events or trends, expectations, and beliefs relating to matters that are not historical in nature. The words “could,” “should,” “feel,” “anticipate,” “preliminary,” “expect,” “believe,” “estimate,” “intend,” “plan,” “will,” “foresee,” “project,” “forecast,” and similar expressions identify forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties relating to the Company’s operations and business environment, all of which are difficult to predict and many of which are beyond the control of the Company. These known and unknown risks and uncertainties could cause actual results to differ materially from those expressed in or implied by such forward-looking statements. The forward-looking statements in this press release only speak as of the date of this press release, and the Company has no duty to update them, even though circumstances may change in the future that impact the Company’s underlying expectations or beliefs. As such, readers are cautioned not to place undue reliance on these forward-looking statements.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/gardner-denver-medical-acquires-tricontinent-scientific-300076117.html

SOURCE Gardner Denver, Inc.

Be the first to comment

Leave a Reply